ASND has been granted a new patent
Oct 09, 2024, 10:35 PM
-2.13%
What does ASND do
Ascendis Pharma A/S is a global biopharmaceutical company developing drug candidates for growth hormone deficiency, endocrinology, CNS disorders, infectious diseases, and diabetes. It operates through multiple subsidiaries in Germany and Denmark.
ASND filed a patent for "effective doses of cnp conjugates" on Tue, May 7, 2024.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.